DiscoverNewsRamp Science, Exploration and Discovery PodcastInnovations in Vision and Cancer Treatment: Ocumetics Lens and Sapu003 Trials Show Promise
Innovations in Vision and Cancer Treatment: Ocumetics Lens and Sapu003 Trials Show Promise

Innovations in Vision and Cancer Treatment: Ocumetics Lens and Sapu003 Trials Show Promise

Update: 2025-10-08
Share

Description

Ocumetics Technology Corp. reports positive outcomes for patients receiving the Ocumetics Accommodating Intraocular Lens, while Oncotelic Therapeutics Inc. prepares for clinical trials of Sapu003 to enhance Everolimus bioavailability. Additionally, Ohio State University Wexner Medical Center researchers discover TexPSR stress pathway impacting immunotherapy efficacy, offering hope for improved cancer treatment outcomes.
Comments 
loading
In Channel
loading
00:00
00:00
1.0x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Innovations in Vision and Cancer Treatment: Ocumetics Lens and Sapu003 Trials Show Promise

Innovations in Vision and Cancer Treatment: Ocumetics Lens and Sapu003 Trials Show Promise

NewsRamp